|
Market Closed -
London S.E.
16:35:25 23/09/2026 BST
|
5-day change | 1st Jan Change | ||
| 191.50 GBX | +2.96% |
|
+19.69% | +49.61% |
| 09-22 | EARNINGS: Origin Enterprises beats operating profit target | AN |
| 09-22 | Diaceutics PLC Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
Main competitors
| P/E (Y) | Price to Book (Y) | PEG (Y) | EV / Sales (Y) | EV / EBITDA (Y) | EV / EBIT (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
 | - | 3.83x | - | 3.21x | 14.74x | 46.92x | -.--% | 211M | |
| -96.33x | 6.77x | 0.25x | 23.31x | 55.99x | -81.14x | -.--% | 64.72B | |
| -720.08x | - | 7.33x | - | - | - | - | 3.89B | |
| 34.01x | 3.34x | 0.61x | 2.49x | 20.19x | 38.77x | 1.34% | 3.41B | |
| 114.27x | 6.24x | 2.93x | 12.63x | 20.06x | 107.95x | 0.32% | 3.23B | |
| -10.45x | - | -0.02x | 6.44x | 15.67x | 66.94x | - | 3.14B | |
| 31.77x | 11.54x | 1.99x | 9.98x | 21.52x | 25.03x | 2.15% | 1.83B | |
| 31.43x | 2.6x | 3.21x | 4.22x | 16.78x | 21.82x | 0.57% | 1.48B | |
| -79.63x | 3.98x | 0.94x | - | - | - | 0.09% | 1.37B | |
| 37.18x | 7.55x | 1.15x | 15.33x | 23.8x | 26.95x | 0.62% | 1.11B | |
| 11.67x | 2.91x | 0.66x | - | - | - | 0.44% | 985M | |
| -1.97x | - | 0.14x | - | - | - | -.--% | 499M | |
| 197.12x | 5.96x | -1.63x | 1.79x | 10.41x | 65.03x | - | 163M | |
| 23.96x | 3.03x | 1.42x | 2.56x | 8.09x | 13.46x | - | 155M | |
| Average | -32.85x | 5.25x | 1.46x | 8.20x | 20.72x | 33.17x | 0.55% | 6.16B | |
| Weighted average by Cap. | -98.83x | 6.53x | 0.79x | 20.40x | 49.13x | -55.74x | 0.15% |
- Stock Market
- Stocks
- DXRX Stock
- Sector Diaceutics PLC
- Sector valuations
Select your edition
All financial news and data tailored to specific country editions
